Interaction between Overweight, Obesity and Smoking on the Risk of Pre-Diabetes and Type 2 Diabetes in Guangdong, China
Abstract
Background: Pre-diabetes mellitus (PDM) is considered a precursor stage of type 2 diabetes mellitus (T2DM) and serves as an early warning sign for the disease. However, most studies only analyze the risk factors of T2DM, ignore the exploration of PDM.
Methods: Here 28,208 patients with T2DM were selected from 5 cities in the Pearl River Delta, Guangdong Province, China in 2017. Then a 1:1 matched case-control study was conducted according to the matching conditions. Finally, 28208 patients with PDM and 28208 patients with normal glucose tolerance (NGT) were matched, and when multiple subjects were matched, the same subjects in the region were preferredOrdered multiple logistic regression was used to analyze the influencing factors of T2DM and PDM. When analyzing the relationship between overweight, obesity, smoking, and T2DM, factors such as age, education level, exercise were adjusted.
Results: Overweight, obesity (OR=1.427, 95%CI:1.388~1.468; OR=1.829,95%CI:1.753~1.908) and smoking (OR=1.161,95%CI:1.113~1.212) were risk factors for the onset of T2DM by ordered multiple logistic regression. There was an additive interaction between overweight obesity and smoking in the developing of T2DM. Moreover, there were 0.196(0.051~0.341) relative excess risk due to the additive interaction, 9.1% (2.0%-16.1%) of T2DM exposed to both risk factors was attributable to the additive interaction, and the risk of T2DM in overweight and obese smokers was 1.203(1.004-1.402) times as high as the sum of risks in the participants exposed to a single risk factor too.
Conclusion: Overweight obesity and smoking are the risk factors for the onset of T2DM.
2. Tseng E, Greer RC, O'Rourke P, et al (2017). Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med, 32(11):1172-1178.
3. Kelly T, Yang W, Chen CS, et al (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond), 32(9):1431-7.
4. NRF C(2016). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 popu-lationbased measurement studies with 19.2 million participants. Lancet, 387(10026):1377-1396.
5. Kim, JH, Seo, DC, Kim, BJ, et al (2019). Association between Cigarette Smoking and New-Onset Diabetes Mellitus in 78,212 Koreans Using Self-Reported Questionnaire and Urine Cotinine. Diabetes Metab J, 44 (3): 426-435.
6. Lillioja S, Bogardus C (1996). Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev, 4（5）: 517-40.
7. Haire -Joshu D, Glasgow RE, Tibbs TL (1999). Smoking and diabetes. Diabetes Care, 22, (11): 1887-1898.
8. Xiong, H, Zhao, P, Ma, F, et al (2023). The effects of interaction between smoking and abdominal obesity on pre-diabetes mellitus. Sci Rep: 15(1):1332.
9. Echouffo-Tcheugui JB, Perreault L, J Li-nong, et al. (2023). Diagnosis and management of prediabetes: a review. JAMA, 329, 1206–1216.
10. Harris KK, Zopey M, Friedman TC (2016). Metabolic effects of smoking cessation. Nat Rev Endocrinol, 12(5):299–308.
11. Canoy D, Wareham N, Luben R, et al (2005). Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity Res, 13(8):1466–75.
12. Cryer PE, Haymond MW, Santiago JV, et al (1976). Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med, 295(11):573‐7.
13. Kolterman OG, Insel J, Saekow M, et al (1980). Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest, 65(6):1272‐84.
14. Arner P, Rydén M(2015). Fatty Acids, Obesity and Insulin Resistance. Obes Facts, 8(2):147‐55.
15. Facchini F, Hollenbeck CB, Jeppesen J, et al (1992). Insulin resistance and cigarette smoking. Lancet, 339:1128–30.
16. Targher G, Alberiche M, Zenere MB, et al (1997). Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 82(11):3619-24.
17. Bajaj M (2012). Nicotine and insulin re-sistance: when the smoke clears.Diabetes, 61(12):3078–80.
18. Luo W, Guo Z , Wu M, et al (2015).Interaction of smoking and obesity on type 2 diabetes risk in a Chinese cohort. Physiol Behav, 139, 240–3.
19. Kahn BB, Flier JS (2000). Obesity and insulin resistance. J Clin Invest, 106(4):473–481.
20. Chang SA (2012). Smoking and type 2 diabetes mellitus. Diabetes Metab J. 36(6):399–403.
21. Kamimura D, Cain LR, Mentz RJ, et al (2018).Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.Circulation, 137:2572-2582.
22. Visser M(1999). Elevated C-Reactive Protein Levels in Overweight and Obese Adults. JAMA, 282(22), 2131-5.
23. Wannamethee SG, Lowe GDO, Shaper AG, et al (2005). Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart Jl, 26(17), 1765–73.
24. Griadil, TI, Bychko, MV, Hechko, MM, et al (2023). Predicting progression type2 diabetes mellitus: A 3-year follow-up study examining risk factors for type2 diabetes in patients with prediabetes. Pol Merkur Lekarsk, 51 (3): 245-249.
| Files | ||
| Issue | Vol 54 No 9 (2025) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v54i9.19857 | |
| Keywords | ||
| Smoking Overweight Obesity Type 2 diabetes mellitus Pre-diabetes mellitus | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
